Some Recent Updates About COVID-19
Hospital success rates when treating COVID-19 patients vary widely.
A distressing issue has come to light regarding the treatment of seriously-ill COVID-19 patients. Where a patient is treated appears to have a very significant effect on the mortality risks of that patient. The connection is so strong that it even overrides (and erases) the previously-claimed higher mortality rankings for certain ethnic groups. For this study, researchers looked at the records of 7,868 patients from 88 locations from January 1, to July 22, 2020.1 The study showed that the mortality risk of a given patient was 99% higher at one hospital, when compared with the mortality risk of a similar patient at another hospital.
During the period covered by this study, 18.4 % (1,447) of the patients died. 53 % (768) of the mortalities were among Black and Hispanic patients. Of the deaths that occurred in hospitals, 17.6 % of the mortalities were Black, 16 % Hispanic, 19.3 % Asian, and 21.1% were non-Hispanic white patients.
Contrary to previous claims, the researchers discovered that logistic regression analyses of the data, allowing for sociodemographic, clinical, and presentation factors, showed that there is probably no association of mortality risk with race and ethnicity. Compared with non-Hispanic White patients, the study showed mortality odds ratios of 0.93 for Black patients, 0.90 for Hispanic patients, and 1.31 for Asian patients.
Discharge from hospital doesn't end COVID-19-associated risks.
A study focused on 1,648 patients admitted into 38 Michigan hospitals from March 16 to July 1 showed that 24.2 % (398) of them died while in the hospital.2 Of the 1250 who were discharged, 6.7 % (84) of them died, and 15.2 % (189) were readmitted into a hospital, within 60 days.
Discharged patients who had spent time in an ICU showed a death rate of 10.4 % (17 of 165) within 60 days of being discharged. That means that there was a total death rate of 63.5 % (257) for the 405 patients who spent time in an ICU, when the in-hospital ICU deaths are included. That leaves a success rate of only 36.5 % (148 of 495 ) for patients treated in an ICU.
The FDA has approved the first COVID-19 diagnostic test for home use.
Available by prescription only, the Lucira test costs about $50, and has been shown to be accurate. It provides results in half an hour or less.3
The Wall Street Journal reports that the Walton family (who control Walmart) is among a group of investors who are backing a startup company that hopes to develop a home COVID-19 test that can be sold at Walmart for about $10.
Hyperglycemia predicts risk of severity for COVID-19 patients.
Regardless of diabetes status, hyperglycemia was found be a predictor of death or other severe outcome in a Spanish study.4 For more than 11,000 patients in 109 Spanish hospitals, those with an abnormally-high blood glucose level at hospital admission were significantly more than twice as likely to die from the disease than those with normal glucose levels (41.4 % vs 15.7 %). And they were also more likely to need to be admitted into an intensive care unit (ICU).
This wasn't part of that study, but please note that a chronic magnesium deficiency is associated with elevated blood glucose levels.5
Be aware of the risk of an allergic reaction to Pfizer/BioNTech vaccines.
While it's true that any vaccine can trigger an allergic reaction in some patients, note that two British Healthcare workers among those who received the first dose of the vaccine in the UK on Dec 8, the first day of the rollout, suffered severe allergic reactions.6 They were presumably given antidotes, and they both recovered.
Based on the best scientific information available, this caveat should not apply to the type of food reactions typically associated with microscopic colitis (MC). Those are IgA-based reactions. Severe allergic reactions (anaphylactic reactions) are IgE-based reactions. That said, those of us who have significant histamine issues could certainly be candidates for that risk (since histamine issues are IgE-based reactions).
This doesn't mean that you absolutely should avoid the vaccines if you have any food allergies (as opposed to food intolerances). But it does imply that if you have any true food allergies (histamine issues), and you decide to get the vaccine, you should definitely alert the healthcare worker who is administering the vaccine that you are at a high risk of an allergic reaction due to a food allergy, so that they can be prepared in case an antidote to a reaction is needed.
1. Wendling, P. (2020, November 19). COVID-19 Outcomes tied to hospital, not just race. Retrieved from https://www.medscape.com/viewarticle/941304?src=mkm_covid_update_201120_mscpedit_&uac=95382HN&impID=2690249&faf=1
2. Kirkner, R. M., MDedge News. (2020, November 19). COVID-19 burdens follow patients after discharge. Retrieved from https://www.medscape.com/viewarticle/941270?src=mkm_covid_update_201120_mscpedit_&uac=95382HN&impID=2690249&faf=1
3. Brooks, M. (2020, November 18). FDA clears first rapid at-home COVID test. Retrieved from https://www.medscape.com/viewarticle/941214?src=mkm_covid_update_201118_MSCPEDIT&uac=95382HN&impID=2684171&faf=1
4. Tucker, M. E, (2020 November 30). Blood glucose on admission predicts COVID-19 severity in all. Retrieved from https://www.medscape.com/viewarticle/941716?src=mkm_covid_update_201130_MSCPEDIT&uac=95382HN&impID=2707601&faf=1
5. Fulop, T. (2020, October 30). What is the role of hypomagnesemia in the etiology of diabetes? Retrieved from https://www.medscape.com/answers/2038394-35970/what-is-the-role-of-hypomagnesemia-in-the-etiology-of-diabetes
6. Triggle, N. and Schraer, R. (2020, December 09). Covid-19 vaccine: Allergy warning over new jab. Retrieved from https://www.bbc.com/news/health-55244122